Wyeth Korea to launch Enbrel, generically engineered protein

Published: 2003-11-24 06:59:00
Updated: 2003-11-24 06:59:00
Wyeth Korea unveiled a plan to launch Enbrel (etanercept), a genetically engineered protein, in Korea at the end of this month.

Enbrel binds to tumor necrosis factor (TNF), a naturally occurring protein in the body, and inhibits its action. Unlike the existing palliative therapies, Enbrel serv...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.